Samama MM - Search Results

1

Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality.

Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M; VTE Impact Assessment Group in Europe (VITAE). Cohen AT, et al. Among authors: samama mm. Thromb Haemost. 2007 Oct;98(4):756-64. Thromb Haemost. 2007. PMID: 17938798

2

Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study.

Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG. Alikhan R, et al. Among authors: samama mm. Blood Coagul Fibrinolysis. 2003 Jun;14(4):341-6. doi: 10.1097/00001721-200306000-00004. Blood Coagul Fibrinolysis. 2003. PMID: 12945875 Clinical Trial.

3

Workshop I: The potential role of new therapies in deep vein thrombosis prophylaxis.

Cohen AT, Gallus AS, Haas S, Monreal M, Pini M, Samama MM. Cohen AT, et al. Among authors: samama mm. Blood Coagul Fibrinolysis. 1999 Aug;10 Suppl 2:S99-102. Blood Coagul Fibrinolysis. 1999. PMID: 10493237 Review. No abstract available.

4

Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.

Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Olsson CG, Turpie AG; MEDENOX Study. Alikhan R, et al. Among authors: samama mm. Arch Intern Med. 2004 May 10;164(9):963-8. doi: 10.1001/archinte.164.9.963. Arch Intern Med. 2004. PMID: 15136304

5

Recommendations on biosimilar low-molecular-weight heparins.

Harenberg J, Kakkar A, Bergqvist D, Barrowcliffe T, Casu B, Fareed J, Mismetti P, Ofosu FA, Raake W, Samama M, Schulman S; Subcommittee on Control of Anticoagulation of the SSC of the ISTH. Harenberg J, et al. J Thromb Haemost. 2009 Jul;7(7):1222-5. doi: 10.1111/j.1538-7836.2009.03349.x. Epub 2009 Mar 23. J Thromb Haemost. 2009. PMID: 19323788 Free article.

6

Prevention and treatment of venous thromboembolism--International Consensus Statement.

Nicolaides AN, Fareed J, Kakkar AK, Comerota AJ, Goldhaber SZ, Hull R, Myers K, Samama M, Fletcher J, Kalodiki E, Bergqvist D, Bonnar J, Caprini JA, Carter C, Conard J, Eklof B, Elalamy I, Gerotziafas G, Geroulakos G, Giannoukas A, Greer I, Griffin M, Kakkos S, Lassen MR, Lowe GD, Markel A, Prandoni P, Raskob G, Spyropoulos AC, Turpie AG, Walenga JM, Warwick D. Nicolaides AN, et al. Int Angiol. 2013 Apr;32(2):111-260. Int Angiol. 2013. PMID: 24402349

7

A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.

Samama MM, Cohen AT, Darmon JY, Desjardins L, Eldor A, Janbon C, Leizorovicz A, Nguyen H, Olsson CG, Turpie AG, Weisslinger N. Samama MM, et al. N Engl J Med. 1999 Sep 9;341(11):793-800. doi: 10.1056/NEJM199909093411103. N Engl J Med. 1999. PMID: 10477777 Free article. Clinical Trial.

8

An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage.

Poller L, Keown M, Ibrahim S, Lowe G, Moia M, Turpie AG, Roberts C, van den Besselaar AM, van der Meer FJ, Tripodi A, Palareti G, Shiach C, Bryan S, Samama M, Burgess-Wilson M, Heagerty A, Maccallum P, Wright D, Jespersen J. Poller L, et al. J Thromb Haemost. 2008 Jun;6(6):935-43. doi: 10.1111/j.1538-7836.2008.02959.x. J Thromb Haemost. 2008. PMID: 18489430 Free article. Clinical Trial.

9

Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study.

Desjardins L, Bara L, Boutitie F, Samama MM, Cohen AT, Combe S, Janbon C, Leizorovicz A, Olsson CG, Turpie AG. Desjardins L, et al. Among authors: samama mm. Arch Pathol Lab Med. 2004 May;128(5):519-26. doi: 10.5858/2004-128-519-COPCPW. Arch Pathol Lab Med. 2004. PMID: 15086284 Free article. Clinical Trial.

10

Primary and secondary prophylaxis of venous thromboembolism with low-molecular-weight heparins: prolonged thromboprophylaxis, an alternative to vitamin K antagonists.

Kher A, Samama MM. Kher A, et al. Among authors: samama mm. J Thromb Haemost. 2005 Mar;3(3):473-81. doi: 10.1111/j.1538-7836.2005.01180.x. J Thromb Haemost. 2005. PMID: 15748236 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

653 results

Search Page